MedTrace Logo

Pharmacokinetic Study of MTC896 Gel in Subjects With Acne

NCT02293018 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-04-17

No results posted yet for this study

Summary

The purpose of this study is to determine the pharmacokinetic properties of topically applied MTC896 Gel following application of 0.75% (w/w) MTC896 Gel once daily and twice daily and 1.5% (w/w) once daily over 4 weeks in the treatment of acne.

Conditions

  • Acne Vulgaris

Interventions

DRUG

0.75% (w/w) MTC896 Gel Once Daily

DRUG

0.75% (w/w) MTC896 Gel Twice Daily

DRUG

1.5% (w/w) MTC896 Gel Once Daily

Sponsors & Collaborators

  • Mimetica Pty Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02293018 on ClinicalTrials.gov